Cargando…
Early Echocardiography and ECG Changes Following Radiotherapy in Patients with Stage II–III HER2-Positive Breast Cancer Treated with Anthracycline-Based Chemotherapy with or without Trastuzumab-Based Therapy
BACKGROUND: Cardiotoxicity from radiotherapy and anti-cancer therapies have been reported in patients with breast cancer. This study aimed to investigate the early echocardiography and ECG changes following radiotherapy in 68 patients ages 30–78 years with stages II–III HER2-positive breast cancer t...
Autores principales: | Toma, Radu Valeriu, Anca, Zgura, Trifănescu, Oana Gabriela, Galeş, Laurenţia Nicoleta, Folea, Antonia Ruxandra, Stanca, Loredana, Bîlteanu, Liviu, Anghel, Rodica M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521333/ https://www.ncbi.nlm.nih.gov/pubmed/37772333 http://dx.doi.org/10.12659/MSM.941754 |
Ejemplares similares
-
Therapies beyond Physiological Barriers and Drug Resistance: A Pilot Study and Review of the Literature Investigating If Intrathecal Trastuzumab and New Treatment Options Can Improve Oncologic Outcomes in Leptomeningeal Metastases from HER2-Positive Breast Cancer
por: Trifănescu, Oana Gabriela, et al.
Publicado: (2023) -
Long-term oncological outcome in patients with cervical cancer after 3 trimodality treatment (radiotherapy, platinum-based chemotherapy, and robotic surgery)
por: Trifanescu, Oana Gabriela, et al.
Publicado: (2021) -
Long-Term Outcome of Patients with Stage II and III Muscle-Invasive Urothelial Bladder Cancer after Multimodality Approach. Which Is the Best Option?
por: Trifanescu, Oana Gabriela, et al.
Publicado: (2022) -
Upstaging and Downstaging in Gliomas—Clinical Implications for the Fifth Edition of the World Health Organization Classification of Tumors of the Central Nervous System
por: Trifănescu, Oana Gabriela, et al.
Publicado: (2023) -
Assessment of Immune Status in Dynamics for Patients with Cancer Undergoing Immunotherapy
por: Xenia Elena, Bacinschi, et al.
Publicado: (2021)